Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 636431
                    [Title] => Hearty news from MSD
                    [Summary] => 
A new investigational study of Ezetimibe/Simvastatin, the cholesterol-lowering medicine from MSD (known as Merck in US and Canada) showed that at dosage of 10/20 mg, it reduced the incidence of first major vascular events  defined as non-fatal heart attacks or cardiac death, stroke or any revascularization procedure  by a highly statistically significant 16.1 percent compared to placebo (p=0.0010).
                    [DatePublished] => 2010-12-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 373011
                    [Title] => Shingles vaccine approved for seniors’ use
                    [Summary] => 






A new and more potent version of the chickenpox vaccine has won federal approval to prevent shingles, the often excruciatingly painful disease that can strike the elderly when the chickenpox virus emerges after lying dormant for decades. The Food and Drug Administration announced Friday that it had licensed the vaccine, Zostavax, to reduce the risk of shingles in adults 60 and older.
                    [DatePublished] => 2006-12-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

MERCK RESEARCH LABORATORIES

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 636431
                    [Title] => Hearty news from MSD
                    [Summary] => 
A new investigational study of Ezetimibe/Simvastatin, the cholesterol-lowering medicine from MSD (known as Merck in US and Canada) showed that at dosage of 10/20 mg, it reduced the incidence of first major vascular events  defined as non-fatal heart attacks or cardiac death, stroke or any revascularization procedure  by a highly statistically significant 16.1 percent compared to placebo (p=0.0010).
                    [DatePublished] => 2010-12-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 373011
                    [Title] => Shingles vaccine approved for seniors’ use
                    [Summary] => 






A new and more potent version of the chickenpox vaccine has won federal approval to prevent shingles, the often excruciatingly painful disease that can strike the elderly when the chickenpox virus emerges after lying dormant for decades. The Food and Drug Administration announced Friday that it had licensed the vaccine, Zostavax, to reduce the risk of shingles in adults 60 and older.
                    [DatePublished] => 2006-12-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Hearty news from MSD

December 7, 2010 - 12:00am

A new investigational study of Ezetimibe/Simvastatin, the cholesterol-lowering medicine from MSD (known as Merck in US and Canada) showed that at dosage of 10/20 mg, it reduced the incidence of first major vascular...

Health And Family

Shingles vaccine approved for seniors’ use

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | December 3, 2006 - 12:00am

A new and more potent version of the chickenpox vaccine has won federal approval to prevent shingles, the often excruciatingly painful disease that can strike the elderly when the chickenpox virus emerges...

Opinion